Incidence of chronic venous disease in the Edinburgh Vein Study
- PMID: 26993896
- DOI: 10.1016/j.jvsv.2012.05.006
Incidence of chronic venous disease in the Edinburgh Vein Study
Abstract
Background: Epidemiologic research in chronic venous disease has focused on prevalence and associated risk factors. Evidence on the risks and incidence that this condition will develop is limited. The aim of this study was to measure the incidence of new varicose veins and chronic venous insufficiency (CVI) in an adult population and to investigate risk factors associated with the development of these conditions.
Methods: The Edinburgh Vein Study is a cohort study of a random sample of the general population. Invitations were sent to 1456 men and women at baseline to participate in a 13-year follow-up examination. Each participant completed a questionnaire on lifestyle and medical history and underwent an examination that included clinical classification of venous disease.
Results: After a mean follow-up of 13.4 (standard deviation, 0.4) years, 880 of 1456 individuals participated (60.4% response). The overall incidence (95% confidence interval [CI]) of C2 varicose veins was 18.2% (15.2%-21.6%), giving an annual incidence rate of 1.4% (1.1%-1.7%), with incidence rates similar in men and women: the 13-year age-adjusted incidence of varicose veins was 15.2% (10.4%-20.0%) in men and 17.4% (13.1%-21.7%) in women (P = .97). The 13-year incidence of varicose veins increased consistently with age from 9.8% in those aged 18 to 34 years to 25.7% in those aged 55 to 64 years (P < .001). The 13-year incidence (95% CI) of CVI was 9.2% (7.0%-11.9%), and the annual incidence rate was 0.7% (0.5%-0.9%). The incidence of CVI was similar in men and women and increased consistently with age (P < .001). Participants with a family history of venous disease were more likely to develop C2 varicose veins (odds ratio, 1.75; 95% CI, 1.12-2.71). Obesity was associated with the development of CVI: the 13-year incidence (95% CI) was 6.1% (3.7%-9.6%) in those who were of normal weight and 23.6% (14.2%-37.0%) in obese participants, with an age-adjusted odds ratio of 3.58 (1.70-7.56).
Conclusions: The Edinburgh Vein Study is one of a few cohort studies to report the incidence of varicose veins and CVI in the general population. The incidence of varicose veins and CVI did not differ significantly by sex and was strongly associated with increasing age. The risk of developing varicose veins was increased in those with a family history, and the risk of CVI was increased in those with higher body mass index.
Copyright © 2013 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Progression of varicose veins and chronic venous insufficiency in the general population in the Edinburgh Vein Study.J Vasc Surg Venous Lymphat Disord. 2015 Jan;3(1):18-26. doi: 10.1016/j.jvsv.2014.09.008. Epub 2014 Nov 1. J Vasc Surg Venous Lymphat Disord. 2015. PMID: 26993676
-
Incidence and risk factors for venous reflux in the general population: Edinburgh Vein Study.Eur J Vasc Endovasc Surg. 2014 Aug;48(2):208-14. doi: 10.1016/j.ejvs.2014.05.017. Epub 2014 Jun 18. Eur J Vasc Endovasc Surg. 2014. PMID: 24951373
-
Risk factors for chronic ulceration in patients with varicose veins: a case control study.J Vasc Surg. 2009 Jun;49(6):1490-8. doi: 10.1016/j.jvs.2009.02.237. J Vasc Surg. 2009. PMID: 19497512
-
The influence of environmental factors in chronic venous insufficiency.Angiology. 2003 Jul-Aug;54 Suppl 1:S19-31. doi: 10.1177/0003319703054001S04. Angiology. 2003. PMID: 12934754 Review.
-
Varicose veins and chronic venous insufficiency.Vasa. 2009 Nov;38(4):293-301. doi: 10.1024/0301-1526.38.4.293. Vasa. 2009. PMID: 19998250 Review.
Cited by
-
Delphi case: Sharing of clinical experiences for improvement in the treatment of chronic venous disease.Front Cardiovasc Med. 2022 Jul 18;9:921235. doi: 10.3389/fcvm.2022.921235. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35924214 Free PMC article.
-
Evaluation of the Isokinetic Calf Muscle Strength and the Range of Motion of Joint in C3 Chronic Venous Insufficiency.Vasc Specialist Int. 2019 Jun;35(2):95-100. doi: 10.5758/vsi.2019.35.2.95. Epub 2019 Jun 30. Vasc Specialist Int. 2019. PMID: 31297359 Free PMC article.
-
Thermal imaging as a diagnostic tool for superficial venous insufficiency - a systematic review.Phlebology. 2025 May;40(4):223-227. doi: 10.1177/02683555241301194. Epub 2024 Nov 12. Phlebology. 2025. PMID: 39531738 Free PMC article.
-
Radiofrequency Thermal Ablation for the Treatment of Chronic Insufficiency of the Saphenous Vein-A Comparative Retrospective Study.Int J Environ Res Public Health. 2023 Feb 14;20(4):3308. doi: 10.3390/ijerph20043308. Int J Environ Res Public Health. 2023. PMID: 36834003 Free PMC article.
-
Nrf2-activating Therapy Accelerates Wound Healing in a Model of Cutaneous Chronic Venous Insufficiency.Plast Reconstr Surg Glob Open. 2020 Nov 20;8(11):e3006. doi: 10.1097/GOX.0000000000003006. eCollection 2020 Nov. Plast Reconstr Surg Glob Open. 2020. PMID: 33299679 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous